↓ Skip to main content

Targeting the p300/CBP Axis in Lethal Prostate CancerTargeting the p300/CBP Axis in Lethal Prostate Cancer

Overview of attention for article published in Cancer Discovery, January 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
74 X users
facebook
1 Facebook page

Citations

dimensions_citation
134 Dimensions

Readers on

mendeley
115 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting the p300/CBP Axis in Lethal Prostate CancerTargeting the p300/CBP Axis in Lethal Prostate Cancer
Published in
Cancer Discovery, January 2021
DOI 10.1158/2159-8290.cd-20-0751
Pubmed ID
Authors

Jonathan Welti, Adam Sharp, Nigel Brooks, Wei Yuan, Christopher McNair, Saswati N. Chand, Abhijit Pal, Ines Figueiredo, Ruth Riisnaes, Bora Gurel, Jan Rekowski, Denisa Bogdan, William West, Barbara Young, Meera Raja, Amy Prosser, Jordan Lane, Stuart Thomson, Jenny Worthington, Stuart Onions, Jonathan Shannon, Silvia Paoletta, Richard Brown, Don Smyth, Gareth W. Harbottle, Veronica S. Gil, Susana Miranda, Mateus Crespo, Ana Ferreira, Rita Pereira, Nina Tunariu, Suzanne Carreira, Antje J. Neeb, Jian Ning, Amanda Swain, David Taddei, SU2C/PCF International Prostate Cancer Dream Team, Matthew J. Schiewer, Karen E. Knudsen, Neil Pegg, Johann S. de Bono

X Demographics

X Demographics

The data shown below were collected from the profiles of 74 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 115 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 15%
Student > Ph. D. Student 16 14%
Student > Master 5 4%
Other 4 3%
Student > Doctoral Student 4 3%
Other 17 15%
Unknown 52 45%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 26 23%
Medicine and Dentistry 11 10%
Agricultural and Biological Sciences 8 7%
Chemistry 3 3%
Business, Management and Accounting 3 3%
Other 10 9%
Unknown 54 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2021.
All research outputs
#962,496
of 25,498,750 outputs
Outputs from Cancer Discovery
#496
of 4,080 outputs
Outputs of similar age
#26,910
of 522,838 outputs
Outputs of similar age from Cancer Discovery
#24
of 151 outputs
Altmetric has tracked 25,498,750 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,080 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 522,838 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 151 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.